Ingredion: Argo Recovery And Tate & Lyle Keep The Re-Rating Case Intact (NYSE:INGR)
· seekingalpha.com
Ingredion Q2 update: Argo production normalizes, margins recover, and Tate & Lyle deal adds upside.
We are back to comment on Ingredion ( INGR ), following our initiation of coverage with a buy rating. Our interest in the company was backed by the strategic ra...